Congenital adrenal hyperplasia (CAH) is caused by disorders of the P450c21B gene, which, with the P45Oc21A pseudogene, lies in the HLA locus on chromosome 6. The near identity of nucleotide sequences and endonuclease cleavage sites in these A and B loci makes genetic analysis of this disease difficult. We used a genomic DNA probe that detects the P45Oc21 genes (A pseudogene, 3.2 kb; B gene, 3.7 kb in Taq leles thus can easily be classified with this new probing strategy, eliminating many ambiguities resulting from probing with cDNA.
Introduction
Congenital adrenal hyperplasia (CAH)' due to deficient 2 1-hydroxylase activity is an autosomal recessive disorder linked to the MHC locus on the short arm of chromosome 6 (1, 2). 2 1-hydroxylase activity is mediated by P45Oc2 1, a microsomal cytochrome P450 enzyme (for review, see reference 3). Two highly homologous genes encoding P450c2 1, formally termed P45OXXIA1 and P45OXXIA2 (4) and commonly termed P450c21 A and P450c21 B, are linked in tandem with C4A and C4B, the genes encoding the fourth component of complement (5, 6) . Only the P450c21B gene is active; P45Oc21A is an inactive pseudogene due to an 8-base deletion causing a frame shift plus a point mutation creating a stop codon (7) (8) (9) . The order and transcriptional orientations ofthese genes have been established (2, 10) . The P450c21 genes are -3.4 kb long and contain 10 exons (7, 8, 11) . A region of 35 kb excompassing a C4 gene and a P450c21 gene has been duplicated in evolution, resulting in this tandem array ofC4 and P45Oc21 genes in mice (12) , probably cattle (13) , and human beings (5, 6 ). The two human P450c21 genes have 98% nucleotide identity (7) (8) (9) , even though this duplication occurred before mammalian speciation; thus, the two loci are evolving in tandem (concerted evolution) (14, 15) . This extremely high degree of nucleotide identity thus indicates extremely frequent crossover events, and makes genetic distinction of the loci difficult (16) .
Some restriction enzymes can distinguish the two P450c21 genes in normal persons. The P45Oc21 A pseudogene is characterized by 3.2-kb Taq I and 12-kb Bgl II fragments, whereas the functional P450c2 lB gene is characterized by 3.7-kb Taq I and 1 1-kb Bgl II fragments. A deletion of the P45Oc2 lB gene, evidenced by an absent 3.7-kb Taq I fragment, was reported in a patient homozygous for HLA-A3, -B47, -DR7, C4A9 1 C4BQO (17) . In hormonally normal individuals, including homozygotes for HLA-A 1, -B8, -DR3, C4AQO C4B 1, absence of the 3.2-kb Taq I fragment suggested deletion of the P450c21A pseudogene (17, 18) . Deletions simultaneously affecting the P450c2 1 gene have been reported in selected populations hav-ing certain HLA and complement types (18) (19) (20) . Schneider et al. used Taq I digests alone to report deletion of the P450c21B gene in 10 of the 16 chromosomes from eight CAH patients who also carried a C4B null allele (20) . However, two of these retained the C4A and C4B genes but lacked the 3.7-kb Taq I fragment and hence probably had gene conversions. Werkmeister et al., excluding CAH patients with HLA-A3, -B47, -DR7, C4A91 C4BQO, reported seven deletions among 30 CAH alleles (21) . Rumsby et al. (22) found the same result for 9 of 40 CAH haplotypes.
However, patients lacking the 3.7-kb Taq I fragment who nonetheless retain the P450c2 lB gene have been reported (23) . This phenomenon is generally termed "gene conversion," as the structure of the P450c2 lB gene is apparently converted to that of the P450c2lA pseudogene (15, (22) (23) (24) (25) (26) (27) (28) . The frequency of gene deletion versus gene conversion thus varies greatly among published studies of small series of patients.
To determine the frequency of various types of genetic defects causing CAH, we studied 57 French families with 68 affected and 165 unaffected family members. For this study we used a new DNA probing tactic using a P450c21 genomic probe, rather than a cDNA probe. This genomic probe can distinguish the P450c2 IA and B genes by the 3.7-and 3.2-kb Taq I fragments, as seen with a cDNA probe, and also by the 2.4-and 2.5-kb fragments lying immediately downstream (3') from these; this greatly simplifies the analysis of this complex locus, and permits the assignment of 114 of 116 affected chromosomes bearing CAH to one of five DNA haplotypes. We find that -76% of chromosomes have grossly intact P450c2 lB genes and, hence, probably carry point mutations.
Chromosomes bearing gene deletions and gene conversions were equally abundant, each -11% of chromosomes carrying CAH.
Methods
Patients and families. 68 CAH patients in 57 families were studied including 47 families with 1 patient, 6 families with 2 patients, and 3 families with 3 patients. As two parents themselves had CAH, these 57 families bore a total of 1 16 affected chromosomes [(2 X 57) + 2 = 1 16].
These families were unrelated and had no known consanguinity. 17 family studies were incomplete because some members were deceased, unavailable for study, or refused study. All available family members underwent HLA-B typing.
All patients were diagnosed by elevated plasma 17-hydroxyprogesterone (I 70HP) and were seen at least twice per year to monitor their hormonal replacement therapy. The patients were classified as having one of the three clinical forms of CAH defined according to standard criteria (2) . CAH with salt wasting (SW) was characterized by onset of hyperkalemia, hyponatremia, dehydration, shock, hyperreninemia, and extremely elevated serum concentrations of 170HP in the first month of life, which required treatment with both mineralocorticoids and glucocorticoids. Females had ambiguous genitalia and males had enlarged hyperpigmented genitalia. The simple virilizing form (SV) was usually diagnosed in late infancy or early childhood; females had ambiguous genitalia recognized at various ages, and males were referred for sexual precocity. Heights and bone ages were markedly advanced, and plasma renin activities were elevated in all SV patients. The nonclassical form (NC) was characterized in girls by normal external genitalia, precocious adrenarche, and elevated 1 70HP responses to ACTH but no clinical or chemical signs of salt loss. Among our 57 CAH families, 42 had SW, 11 had SV, 4 had NC, and 2 parents also had NC.
HLA and complement typing. Leukocyte HLA typing was done by the stage microlymphotoxicity test (29, 30) . Complement C2, Bf, and C4 types were determined as described (31) , and C4 variants were identified by high-voltage agarose gel electrophoresis with subsequent immunofixation and hemolytic overlay or immunoblotting using anti-C4A and anti-C4B MAb (gifts from Dr. G. O'Neill, American Red Cross, Miami, FL) (32) .
DNA blotting studies. Human leukocyte DNA was digested with restriction endonucleases, electrophoresed in 0.7 or 1.0% agarose gels, and analyzed by Southern blotting to nylon membranes by standard procedures. Blots were probed with a 2.7-kb Eco RI fragment of the murine P450c2 1A gene (12) under low-stringency conditions and with human P450c21 cDNA (25) under high-stringency conditions. Highstringency conditions were 2X SSC (SSC is 0.15 M NaCl, 0.015 M Na citrate), 50% deionized formamide, 50 mM Tris-HCl (pH 7.5), 0.02% wt/vol each of polyvinylpyrrolidone, Ficoll, and BSA, 1% NaDodSO4, and 100 ,g/ml denatured salmon sperm DNA (Sigma Chemical Co., St. Louis, MO). Low stringency conditions substituted 6X SSC and 40% deionized formamide in the above recipe. Overnight prehybridization and 24-h hybridization were at 42°C. After hybridization, nylon membranes were washed twice with 2X SSC at 22°C, then three times with 0.1X SSC, 1% NaDodSO4 (high stringency) or 2X SSC 1% NaDodSO4 (low stringency) for 30 min at 65°C. After a final wash at 22°C, the wet membranes were exposed to Kodak XAR-5 films for 5-10 d at -700C with intensifying screens. The validity of the data obtained with the mouse genomic DNA probe was confirmed by reprobing all Taq I digests with the human P450c2 1 cDNA (see examples in Fig. 3, below) . Some Taq I blots were also hybridized with a 476-bp Bam HI-Kpn I restriction fragment from the full-length C4 cDNA clone, pAT-A (33) corresponding at the 5' C4 region, using high-stringency conditions.
Results
Study population. All affected individuals, obligate heterozygotes, and other family members underwent HLA-B typing. The distribution of HLA-B alleles among 78 unaffected chromosomes from phenotypically normal family members was the same as among a published normal French population (Table I , columns a and b). By contrast, the distribution of HLA-B alleles among affected chromosomes differed from our unaffected chromosomes. HLA-B8 was found less frequently and HLA-B 14 and -B47 were found more commonly on chromosomes bearing CAH (Table I ). The incidence of HLA-B47 in our patient population is lower than in some other studies (34, 35 bearing CAH and 84 normal chromosomes from family members (including the 78 chromosomes in Table I ). Taq I digests of DNA were probed with a murine 2.7-kb Eco RI genomic DNA fragment extending over 800 bases downstream from the 3' Taq I site of the P450c21 genes (12) . This probe detects the 3.2-and 3.7-kb fragments characteristic of the P450c2 IA and B genes, respectively, and also detects the adjacent downstream Taq I fragments that cannot be detected by the cDNA probe ( 12 -kb Bgl II bands are darker because there is an extra P450c2 1A pseudogene on each chromosome. In the IlIb heterozygote this difference in intensity is less, about the 3:2 ratio expected; however, Southern blots are inherently non-quantitative and thus assignment of a patient as type IlIb must be done in conjunction with HLA and complement data and family studies. Haplotype IV, gene conversion. In the IVa homozygote, the 3.7-kb Taq I band is absent but the other five bands remain. In the IVb heterozygote, the 3.7-kb band is fainter than the 3.2-kb band because only the heterozygous chromosome bearing haplotype I contributes this band. Haplotype V, gene deletion. (Table II) .
CAH haplotypes IV and V. Haplotypes IV and V are the ones of greatest interest, representing gene conversion and gene deletion, respectively. Among our study of 1 16 chromosomes, haplotypes IV and V each represent 1 1.2% of the total (13 of 116). In the homozygous state, both haplotypes completely lack the 3.7-kb Taq I band normally associated with the functional P45Oc21 B gene, a pattern generally interpreted as diagnostic of gene deletion. However, haplotype IV retains both the 2.4-and 2.5-kb Taq I bands seen only with the genomic probe, whereas haplotype V lacks the 2.4-kb band. Homozygotes for haplotype IV retain both the 1 1-and 12-kb Bgl II fragments yielding equal autoradiographic intensities, whereas homozygotes for haplotype V lack the 12-kb Bgl II fragment normally associated with the P450c2 IA pseudogene. In haplotype IV both P450c21 genes are present, but there is a change in the structure of the 5' end of the P450c2 lB gene, converting it to the structure of a P450c2 IA gene. Thus, a chromosome bearing haplotype IV has two 3.2-kb Taq I fragments and no 3.7-kb Taq I fragments, but most other restriction endonuclease recognition sites are the same as in normal DNA, and both the C4A and C4B genes are retained and function normally (Table V) The numbers under "homozygous" or "heterozygous" refer to numbers of patients. The numbers under "haplotype" refer to the number of affected chromosomes (total, 116). The unaffected haplotypes are from 84 normal chromosomes borne by obligate heterozygotes. (Table II) . Deletion of (Table  IV) . Five of these carried HLA-B8, which is associated with deletion of the P450c21 A pseudogene (18) (19) (20) , and complement typing showed six C4AQO and four C4A3,BQO alleles.
To confirm apparent deletions of the C4A or C4B genes, four normal chromosomes were probed with C4 cDNA (Table  IV and Fig. 3 ). Absence of a 7.0-kb Taq I band and presence of a 6.4-kb Taq I band are characteristic of deletion of the C4A gene (20) . This pattern segregates with the complotype C4AQO and confirms deletion of the C4A gene and the P450c2 IA pseudogene (Fig. 3, family C, haplotype b) . By contrast, presence of the 7.0-kb band and absence of the C4B Taq I fragments (6.0 or 5.4 kb) is characteristic of deletion of the C4B gene. This pattern segregates with the complotype C4A4,BQO and confirms a deletion encompassing the C4B gene and the P450c2 1A pseudogene (Fig. 3, family D, Correlation of restriction endonuclease haplotypes with HLA and complement haplotypes. Linkage disequilibrium between certain HLA types and CAH (34) (35) (36) is also found in our study, indicating that our patient population is typical and representative (Table I) . Complement typing should be even more informative because the C4 loci are so closely linked to the P450c21 genes; however, the great technical difficulty in performing C4 typing prevented its unambiguous determination in eight families. C4AQO was closely associated with haplotype II (deletion of the P450c2 IA pseudogene), but its overall incidence was lower on chromosomes bearing CAH alleles (9.9%) than on normal chromosomes (20.8%) (Table III) . By contrast, C4BQO was found with equal frequency among normal and CAH-bearing chromosomes, but all chromosomes bearing a P450c2 lB gene deletion also bore C4BQO (12 of 12), consistent with a 30-kb deletion encompassing the C4B gene. One chromosome bearing haplotype IV also bore C4BQO and C4A2A2, suggesting that the C4B gene was converted to a C4A in conjunction with conversion of the P450c2 lB gene to a P450c21A pseudogene. Similar events have been described on other chromosomes encoding CAH (37, 38), but all our other chromosomes bearing haplotype IV had markers for both C4 genes.
Some extended supratypes are clearly linked to CAH (Table V) A24  A3  A29  A3  A26  A24  A29  A3  A3  Al  A3  A3  A3  A2  A3  A30  A3  A32   Al  All   B58  B35  B55  B47  B5  B35  B44  B47  B47  B8  B35  B35  B47  B18  B27  B49  B47  B12  B41 (16, (23) (24) (25) (26) (27) (28) 37) . Gene conversion can be most easily conceptualized as resulting from two unequal crossover events, but many other mechanisms may also be involved (see reference 15 for review and references). Gene conversions in CAH have been documented by Southern blotting studies (23) (24) (25) (26) (27) and by DNA sequencing (9, 27, 41) . Simple Taq I digests alone probed with P450c21 cDNA cannot distinguish gene conversion (haplotype IV) from gene deletion (haplotype V); hence, the relative incidence of these two classes of mutations has been unclear and somewhat contro- versial. The use of both Taq I and Bgl II digests in conjunction with a genomic probe detecting the Taq I fragments 3' to the P450c21 genes now greatly simplifies this task. We found equal numbers of chromosomes bearing deletion or conversion, 13 of 116 or 11.2% for each lesion. Other studies report greatly varying relative incidences ofthese two lesions (24) (25) (26) (27) (28) , presumably due to the small number of patients studied or to population differences, or both.
The available data now localize the region where the presumed gene conversion event(s) must occur. No reported examples of gene conversion modify the sizes of the 11-and 12-kb Bgl II fragments or, in our study, of the 2.4-and 2.5-kb Taq I fragments. These observations and the published sequencing data (27, 42) delineate the 3' end of the conversion event as lying downstream from the 8-bp deletion in exon 3 and upstream from exon 4 of the P450c21A pseudogene. Because C4B protein is detected in seven ofeight gene conversion haplotypes, the 5' limit probably lies downstream (3') from the C4B gene. Similarly, the limits of the gene deletion in chromosomes bearing haplotype V should include the 3' end of the P450c21A pseudogene to the 5' end of the P45Oc21 B gene, in a 30-kb deletion producing a hybrid, nonfunctional P450c2 lA/ B pseudogene giving 3.2-and 2.5-kb Taq I fragments.
Our studies thus show that most chromosomes encoding CAH carry point mutations of the P45Oc2 lB gene. These may be found on three haplotypes, here termed haplotypes I, II, and III, which together encompass 75.9% of the chromosomes in our study. Determination of the genetic lesions in these chromosomes requires cloning and sequencing the affected DNA.
Specific amplification of affected sequences by polymerase chain reaction technology (43) is not effective, because the 98% sequence identity of the P450c2 IA and B genes prohibits suitably specific priming (Y. Morel and W. L. Miller, unpublished observations). Of the remaining CAH chromosomes, equal numbers (11.2%) bear gene deletions (haplotype V) and gene conversions (haplotype IV), while a small number (1.7%) still escape characterization by our procedures. Our procedures, using a genomic probe extending 3' to the P450c2 IA and B genes, now permit simple and accurate characterization of > 98% of chromosomes encoding CAH. We propose that Taq I digests alone are sufficient for accurate genetic diagnosis in -98% of cases if family studies are done and ifthe blots are examined with a genomic probe extending 3' to the P450c21 genes (e.g., the 3.1-kb Eco RI/Bam HI fragment of the human genes); examination of these blots with a 5' C4 cDNA probe can provide useful confirmation.
